Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases.
Pink
Daniel
D
Schoeler
Dagmar
D
Lindner
Tanja
T
Thuss-Patience
Peter C
PC
Kretzschmar
Albrecht
A
Knipp
Heike
H
Vanhoefer
Udo
U
Reichardt
Peter
P
D015746:Abdominal Pain / Q000175:diagnosis / Q000209:etiology; D000328:Adult; D001549:Benzamides; D001786:Blood Glucose / Q000032:analysis; D003131:Combined Modality Therapy; D013505:Digestive System Surgical Procedures; D005500:Follow-Up Studies; D046152:Gastrointestinal Stromal Tumors / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D000068877:Imatinib Mesylate; D007335:Insulin-Like Growth Factor II / Q000009:adverse effects* / Q000096:biosynthesis; D007421:Intestine, Small / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000150:complications* / Q000175:diagnosis; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D001549:Benzamides; D001786:Blood Glucose; D010879:Piperazines; D011743:Pyrimidines; D007335:Insulin-Like Growth Factor II; D000068877:Imatinib Mesylate; D005947:Glucose